Concepedia

Kirandeep Samby

KS

Statistics

Publications

14

Citations

589

H-Index

12

Active since

2017

Affiliations

Medicines for Malaria Venture(Current)

University of Pennsylvania

Drugs for Neglected Diseases Initiative

Jawaharlal Nehru University

Thomas Jefferson University

Kirandeep Samby is an author at Medicines for Malaria Venture specializing in drug discovery, pharmacology, and medicine.

Publications per year

2017–2022

14

Publications

14

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2

Mark Dittmar, Jae Seung Lee, Kanupriya Whig et al. · Cell Reports · 2021 · 250 citations · Full text

Medicine, Pharmacology, Drug Discovery +12

Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2

Mark Dittmar, Jae Seung Lee, Kanupriya Whig et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 47 citations · Full text

Medicine, Infectious Diseases, Pharmacology +10

Drug Repurposing Screens Reveal FDA Approved Drugs Active Against SARS-CoV-2

Mark Dittmar, Jae Seung Lee, Kanupriya Whig et al. · SSRN Electronic Journal · 2020 · 42 citations · Full text

Medicine, Infectious Diseases, Pharmacology +10

Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma

Wilson Lim, Bertrand Nyuykonge, Kimberly Eadie et al. · PLoS neglected tropical diseases · 2022 · 37 citations · Full text

Pharmacy, Microbiology, Pharmacology +15

The Pandemic Response Box─Accelerating Drug Discovery Efforts after Disease Outbreaks

Kirandeep Samby, Dominique Besson, Anirban Dutta et al. · ACS Infectious Diseases · 2022 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

1–5 of 14